I, K., MR, I., ABM, K., L, N., SA, P., MA, S., . . . D, D. (2025). Comparative Effectiveness of Glucagon-like Peptide-1- Receptor Agonists in Patients With Heart Failure With Preserved or Minimally Reduced Ejection Fraction: A Comprehensive Bayesian Network Meta-Analysis and Network Meta-Regression. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 31(9), 1133. https://doi.org/10.1016/j.eprac.2025.06.005
Chicago Style (17th ed.) CitationI, Khalil, et al. "Comparative Effectiveness of Glucagon-like Peptide-1- Receptor Agonists in Patients With Heart Failure With Preserved or Minimally Reduced Ejection Fraction: A Comprehensive Bayesian Network Meta-Analysis and Network Meta-Regression." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 31, no. 9 (2025): 1133. https://doi.org/10.1016/j.eprac.2025.06.005.
MLA (9th ed.) CitationI, Khalil, et al. "Comparative Effectiveness of Glucagon-like Peptide-1- Receptor Agonists in Patients With Heart Failure With Preserved or Minimally Reduced Ejection Fraction: A Comprehensive Bayesian Network Meta-Analysis and Network Meta-Regression." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 31, no. 9, 2025, p. 1133, https://doi.org/10.1016/j.eprac.2025.06.005.